Assignee profile:

Emergent Product Development Seattle, LLC

City:

Seattle, Washington

Country:

United States

Published Applications:

24

Last publication date:

2014-06-05

Patent Grants:

11

Last grant date:

2015-04-14

Top Inventors for applications by Emergent Product Development Seattle, LLC

These are the the leading inventors for applications assigned to Emergent Product Development Seattle, LLC:

Recent patent applications by Emergent Product Development Seattle, LLC

Emergent Product Development Seattle, LLC based in Seattle, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2014-06-05
US20140154252A1
Chemistry; metallurgy

SINGLE-CHAIN MULTIVALENT BINDING PROTEINS WITH EFFECTOR FUNCTION

#2 | 2014-06-05
US20140154250A1
Chemistry; metallurgy

SINGLE-CHAIN MULTIVALENT BINDING PROTEINS WITH EFFECTOR FUNCTION

#3 | 2014-05-22
US20140141022A1
Chemistry; metallurgy

SINGLE-CHAIN MULTIVALENT BINDING PROTEINS WITH EFFECTOR FUNCTION

#4 | 2014-05-08
US20140127203A1
Chemistry; metallurgy

SINGLE-CHAIN MULTIVALENT BINDING PROTEINS EFFECTOR FUNCTION

#5 | 2014-03-13
US20140072562A1
Human necessities

B-CELL REDUCTION USING CD37-SPECIFIC AND CD20-SPECIFIC BINDING MOLECULES

#6 | 2013-12-19
US20130336977A1
Chemistry; metallurgy

SINGLE-CHAIN MULTIVALENT BINDING PROTEINS WITH EFFECTOR FUNCTION

#7 | 2013-08-01
US20130195850A1
Chemistry; metallurgy

CD3 IMMUNOTHERAPEUTICS AND USES THEREOF

#8 | 2013-07-25
US20130189261A1
Human necessities

TCR Complex Immunotherapeutics

#9 | 2013-06-06 ✅ Patent 9,005,612 granted on 2015-04-14
US20130142793A1
Chemistry; metallurgy

Binding domain-immunoglobulin fusion proteins

#10 | 2013-05-23
US20130129723A1
Chemistry; metallurgy

Heterodimer Binding Proteins and Uses Thereof

#11 | 2013-04-18
US20130095097A1
Chemistry; metallurgy

Polypeptide Heterodimers and Uses Thereof

#12 | 2013-04-11
US20130089554A1
Chemistry; metallurgy

RON Binding Constructs and Methods of Use Thereof

#13 | 2012-08-23 ✅ Patent 8,853,366 granted on 2014-10-07
US20120213773A1
Chemistry; metallurgy

Binding domain-immunoglobulin fusion proteins

#14 | 2012-02-09 ✅ Patent 8,409,577 granted on 2013-04-02
US20120034245A9
Chemistry; metallurgy

Single chain multivalent binding proteins with effector function

#15 | 2011-10-20 ✅ Patent 8,383,106 granted on 2013-02-26
US20110256125A1
Chemistry; metallurgy

Materials and methods for improved immunoglycoproteins

#16 | 2011-09-15
US20110223164A1
Chemistry; metallurgy

BINDING DOMAIN-IMMUNOGLOBULIN FUSION PROTEINS

#17 | 2011-09-08
US20110217302A1
Chemistry; metallurgy

TCR Complex Immunotherapeutics

#18 | 2011-07-14 ✅ Patent 8,333,966 granted on 2012-12-18
US20110171208A1
Human necessities

CD37 immunotherapeutics and uses thereof

#19 | 2011-06-16 ✅ Patent 8,632,774 granted on 2014-01-21
US20110142851A1
Chemistry; metallurgy

Antagonists of IL-6

#20 | 2011-05-05 ✅ Patent 8,188,237 granted on 2012-05-29
US20110105729A1
Chemistry; metallurgy

Binding domain-immunoglobulin fusion proteins

#21 | 2011-04-21 ✅ Patent 8,197,810 granted on 2012-06-12
US20110091461A1
Chemistry; metallurgy

Binding domain-immunoglobulin fusion proteins

#22 | 2010-02-11 ✅ Patent 8,147,835 granted on 2012-04-03
US20100034820A1
Chemistry; metallurgy

Binding domain-immunoglobulin fusion proteins

#23 | 2009-11-05 ✅ Patent 9,101,609 granted on 2015-08-11
US20090274692A1
Human necessities

CD37 immunotherapeutic and combination with bifunctional chemotherapeutic thereof

#24 | 2005-09-15 ✅ Patent 8,106,161 granted on 2012-01-31
US20050202028A1
Chemistry; metallurgy

Binding domain-immunoglobulin fusion proteins

AssigneeID:

17545 ⎘